India’s Contract Research, Development, and Manufacturing Organization (CRDMO) sector is on the brink of monumental growth. According to a report by Macquarie Equity Research, the industry is projected to expand from approximately USD 7 billion to USD 14 billion by 2028. This robust growth is driven by a 14 percent compound annual growth rate (CAGR), fueled by the rising wave of pharmaceutical outsourcing and a supportive regulatory environment.
About the Author
